Director, Search and Evaluation at Bristol-Myers Squibb

Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

MD, PhD, PharmD, or other advanced degree in the biomedical field required
Minimum 10 years’ experience within the biopharmaceutical industry or related biotech/healthcare practice (e.g., consulting, investment banking, venture capital); significant previous S&E/BD experience highly desirable
Scientific knowledge in specific therapeutic areas with deep understanding of drug development processes from discovery to regulatory approval
Strong analytical, communication, and leadership skills
A proven record of effectively supporting discovery, clinical development or business development projects
Proven ability to efficiently lead multiple projects in a matrixed environment with a high degree of independence
Consistently deliver on commitments with a sense of urgency
Demonstrated ability to effectively communicate ideas and lead others to accomplish challenging objectives

Responsibilities

Lead key strategic S&E efforts for BD in the China market; 80% dedicated to global strategic efforts, 20% dedicated to China 2030 strategy
Lead S&E efforts for global BD opportunities across therapeutic areas such as Oncology, Immunoscience, Cardiovascular and Neuroscience creating a point-of-view in how we leverage China’s biotech ecosystem to source innovation for BMS globally
Demonstrate leadership and scientific rigor while working closely with internal stakeholders such as Enterprise Strategy, R&D and Commercial and potential external partners; seen as an expert in the ecosystem providing points of view on sourced innovative assets in China
Lead and conduct initial triaging and assessment of inbound BD opportunities (initial focus on IND-staged/near-proof of concept/proof of concept; post-proof of concept/later staged opportunities also in scope however opportunity dependent)
Lead and conduct proactive search and external outreach in therapeutic areas to identify and initially qualify partnering or acquisition opportunities fitting BMS BD priorities
Serve as thought partner to facilitate formulation of therapeutic area strategy based on China’s biotech ecosystem (e.g., focus indications, target MOAs, potential partners, etc.) while driving the execution of external business development elements
Partner with cross-functional teams to deliver assessments of external opportunities for BMS governance endorsement, including leading scientific evaluations and due diligence
Collaborate with local and global Transaction BD and Corporate Development colleagues to support agreement negotiation and contracting
Ensure consistent excellence and standards across global S&E, execution, compliance etc
Ability to multi-task in balancing large book of work while ensuring consistent attention and prioritization of most critical and visible projects
Lead and participate in BD external partnering events (e.g. BIO, BIO Asia, BMS Partnering Days) and technical / scientific meetings, and support the preparation of materials such as presentations, FAQ and related documents

Skills

Business Development

Strategic Partnerships

Oncology

Immunoscience

Cardiovascular

Neuroscience

Biotech Ecosystem

Opportunity Assessment

External Outreach

IND Evaluation

Proof of Concept

China Market Strategy

R&D Collaboration

Commercial Strategy

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free